Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
Open Access
- 24 October 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (46), E3186-E3195
- https://doi.org/10.1073/pnas.1119964109
Abstract
Although macrophages are widely recognized to have a profibrotic role in inflammation, we have used a highly tractable CCl4-induced model of reversible hepatic fibrosis to identify and characterize the macrophage phenotype responsible for tissue remodeling: the hitherto elusive restorative macrophage. This CD11Bhi F4/80int Ly-6Clo macrophage subset was most abundant in livers during maximal fibrosis resolution and represented the principle matrix metalloproteinase (MMP) -expressing subset. Depletion of this population in CD11B promoter–diphtheria toxin receptor (CD11B-DTR) transgenic mice caused a failure of scar remodeling. Adoptive transfer and in situ labeling experiments showed that these restorative macrophages derive from recruited Ly-6Chi monocytes, a common origin with profibrotic Ly-6Chi macrophages, indicative of a phenotypic switch in vivo conferring proresolution properties. Microarray profiling of the Ly-6Clo subset, compared with Ly-6Chi macrophages, showed a phenotype outside the M1/M2 classification, with increased expression of MMPs, growth factors, and phagocytosis-related genes, including Mmp9, Mmp12, insulin-like growth factor 1 (Igf1), and Glycoprotein (transmembrane) nmb (Gpnmb). Confocal microscopy confirmed the postphagocytic nature of restorative macrophages. Furthermore, the restorative macrophage phenotype was recapitulated in vitro by the phagocytosis of cellular debris with associated activation of the ERK signaling cascade. Critically, induced phagocytic behavior in vivo, through administration of liposomes, increased restorative macrophage number and accelerated fibrosis resolution, offering a therapeutic strategy to this orphan pathological process.Keywords
This publication has 60 references indexed in Scilit:
- Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74Proceedings of the National Academy of Sciences of the United States of America, 2011
- Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regressionJournal of Hepatology, 2011
- Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repairProceedings of the National Academy of Sciences of the United States of America, 2011
- Macrophages Expressing Heme Oxygenase-1 Improve Renal Function in Ischemia/Reperfusion InjuryMolecular Therapy, 2010
- Macrophages: Master Regulators of Inflammation and FibrosisSeminars in Liver Disease, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Interleukin-10 Expression in Macrophages during Phagocytosis of Apoptotic Cells Is Mediated by Homeodomain Proteins Pbx1 and Prep-1Immunity, 2007
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005